APO Research
Talk to an analyst

APO RESEARCH · REPORT

Venlafaxine Hydrochloride Extended-Release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Venlafaxine Hydrochloride Extended-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026186 pages

Choose your research edition.

Industry ResearchVenlafaxine Hydrochloride Extended-Release Capsules Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Venlafaxine Hydrochloride Extended-Release Capsules Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Venlafaxine Hydrochloride Extended-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venlafaxine Hydrochloride Extended-Release Capsules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Venlafaxine Hydrochloride Extended-Release Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Venlafaxine Hydrochloride Extended-Release Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Venlafaxine Hydrochloride Extended-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Venlafaxine Hydrochloride Extended-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venlafaxine Hydrochloride Extended-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Venlafaxine Hydrochloride Extended-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules include Teva, Pfizer, Beijing Fuyuan Pharm, Zydus, Torrent Pharmaceuticals, Macleods Pharmaceuticals and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Venlafaxine Hydrochloride Extended-Release Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Venlafaxine Hydrochloride Extended-Release Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Venlafaxine Hydrochloride Extended-Release Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Venlafaxine Hydrochloride Extended-Release Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Venlafaxine Hydrochloride Extended-Release Capsules Segment by Company

Teva

Pfizer

Beijing Fuyuan Pharm

Zydus

Torrent Pharmaceuticals

Macleods Pharmaceuticals

Cipla

Venlafaxine Hydrochloride Extended-Release Capsules Segment by Type

75mg

37.5mg

150mg

Venlafaxine Hydrochloride Extended-Release Capsules Segment by Application

Clinic

Hospital

Recovery Center

Venlafaxine Hydrochloride Extended-Release Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venlafaxine Hydrochloride Extended-Release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venlafaxine Hydrochloride Extended-Release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venlafaxine Hydrochloride Extended-Release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Venlafaxine Hydrochloride Extended-Release Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Venlafaxine Hydrochloride Extended-Release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Venlafaxine Hydrochloride Extended-Release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Venlafaxine Hydrochloride Extended-Release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Venlafaxine Hydrochloride Extended-Release Capsules Industry Trends Table 2. Venlafaxine Hydrochloride Extended-Release Capsules Industry Drivers Table 3. Venlafaxine Hydrochloride Extended-Release Capsules Industry Opportunities and Challenges Table 4. Venlafaxine Hydrochloride Extended-Release Capsules Industry Restraints Table 5. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Manufacturers Table 9. Global Venlafaxine Hydrochloride Extended-Release Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Venlafaxine Hydrochloride Extended-Release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Venlafaxine Hydrochloride Extended-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Venlafaxine Hydrochloride Extended-Release Capsules Manufacturers, Product Type & Application Table 13. Global Venlafaxine Hydrochloride Extended-Release Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Venlafaxine Hydrochloride Extended-Release Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 75mg Table 17. Major Manufacturers of 37.5mg Table 18. Major Manufacturers of 150mg Table 19. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2021-2026) & (K Units) Table 21. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2027-2032) & (K Units) Table 22. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2021-2026) Table 23. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2027-2032) Table 24. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2021-2026) & (K Units) Table 26. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2027-2032) & (K Units) Table 27. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2021-2026) Table 28. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Recovery Center Table 32. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2021-2026) & (K Units) Table 34. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2027-2032) & (K Units) Table 35. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2021-2026) Table 36. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2027-2032) Table 37. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2021-2026) & (K Units) Table 39. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2027-2032) & (K Units) Table 40. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2021-2026) Table 41. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2027-2032) Table 42. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Region (2021-2026) Table 45. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2026) & (K Units) Table 49. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2027-2032) & (K Units) Table 50. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2026) & (K Units) Table 52. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2021-2026) Table 63. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 68. Teva Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 73. Pfizer Recent Development Table 74. Beijing Fuyuan Pharm Company Information Table 75. Beijing Fuyuan Pharm Business Overview Table 76. Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 78. Beijing Fuyuan Pharm Recent Development Table 79. Zydus Company Information Table 80. Zydus Business Overview Table 81. Zydus Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zydus Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 83. Zydus Recent Development Table 84. Torrent Pharmaceuticals Company Information Table 85. Torrent Pharmaceuticals Business Overview Table 86. Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 88. Torrent Pharmaceuticals Recent Development Table 89. Macleods Pharmaceuticals Company Information Table 90. Macleods Pharmaceuticals Business Overview Table 91. Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 93. Macleods Pharmaceuticals Recent Development Table 94. Cipla Company Information Table 95. Cipla Business Overview Table 96. Cipla Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Cipla Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio Table 98. Cipla Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Venlafaxine Hydrochloride Extended-Release Capsules Distributors List Table 102. Venlafaxine Hydrochloride Extended-Release Capsules Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Venlafaxine Hydrochloride Extended-Release Capsules Product Image Figure 2. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (2021-2032) & (K Units) Figure 5. Global Venlafaxine Hydrochloride Extended-Release Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Venlafaxine Hydrochloride Extended-Release Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 75mg Image Figure 9. 37.5mg Image Figure 10. 150mg Image Figure 11. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2021-2032) Figure 14. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Recovery Center Image Figure 20. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2021-2032) Figure 23. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2021-2032) Figure 26. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2021-2032) Figure 28. U.S. Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2021-2032) Figure 33. Germany Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2021-2032) Figure 40. China Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2021-2032) Figure 48. Brazil Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Venlafaxine Hydrochloride Extended-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 59. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Venlafaxine Hydrochloride Extended-Release Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Venlafaxine Hydrochloride Extended-Release Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 75mg
  • 37.5mg
  • 150mg
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Teva
  • Pfizer
  • Beijing Fuyuan Pharm
  • Zydus
  • Torrent Pharmaceuticals
  • Macleods Pharmaceuticals
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Dynamics
  1. 2.1 Venlafaxine Hydrochloride Extended-Release Capsules Industry Trends
  2. 2.2 Venlafaxine Hydrochloride Extended-Release Capsules Industry Drivers
  3. 2.3 Venlafaxine Hydrochloride Extended-Release Capsules Industry Opportunities and Challenges
  4. 2.4 Venlafaxine Hydrochloride Extended-Release Capsules Industry Restraints
3 Venlafaxine Hydrochloride Extended-Release Capsules Market by Manufacturers
  1. 3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Venlafaxine Hydrochloride Extended-Release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Venlafaxine Hydrochloride Extended-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Venlafaxine Hydrochloride Extended-Release Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Venlafaxine Hydrochloride Extended-Release Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Venlafaxine Hydrochloride Extended-Release Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Venlafaxine Hydrochloride Extended-Release Capsules Tier 1, Tier 2, and Tier 3
4 Venlafaxine Hydrochloride Extended-Release Capsules Market by Type
  1. 4.1 Venlafaxine Hydrochloride Extended-Release Capsules Type Introduction
  2. 4.1.1 75mg
  3. 4.1.2 37.5mg
  4. 4.1.3 150mg
  5. 4.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type
  6. 4.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2021-2032)
  8. 4.2.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2021-2032)
  9. 4.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type
  10. 4.3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2021-2032)
  12. 4.3.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2021-2032)
5 Venlafaxine Hydrochloride Extended-Release Capsules Market by Application
  1. 5.1 Venlafaxine Hydrochloride Extended-Release Capsules Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application
  6. 5.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application
  10. 5.3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2021-2032)
6 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region
  1. 6.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region
  1. 7.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region
  2. 7.1.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032)
  8. 7.2.2 North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Beijing Fuyuan Pharm
  14. 8.3.1 Beijing Fuyuan Pharm Company Information
  15. 8.3.2 Beijing Fuyuan Pharm Business Overview
  16. 8.3.3 Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  18. 8.3.5 Beijing Fuyuan Pharm Recent Developments
  19. 8.4 Zydus
  20. 8.4.1 Zydus Company Information
  21. 8.4.2 Zydus Business Overview
  22. 8.4.3 Zydus Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  24. 8.4.5 Zydus Recent Developments
  25. 8.5 Torrent Pharmaceuticals
  26. 8.5.1 Torrent Pharmaceuticals Company Information
  27. 8.5.2 Torrent Pharmaceuticals Business Overview
  28. 8.5.3 Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  30. 8.5.5 Torrent Pharmaceuticals Recent Developments
  31. 8.6 Macleods Pharmaceuticals
  32. 8.6.1 Macleods Pharmaceuticals Company Information
  33. 8.6.2 Macleods Pharmaceuticals Business Overview
  34. 8.6.3 Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  36. 8.6.5 Macleods Pharmaceuticals Recent Developments
  37. 8.7 Cipla
  38. 8.7.1 Cipla Company Information
  39. 8.7.2 Cipla Business Overview
  40. 8.7.3 Cipla Venlafaxine Hydrochloride Extended-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cipla Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio
  42. 8.7.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Venlafaxine Hydrochloride Extended-Release Capsules Value Chain Analysis
  2. 9.1.1 Venlafaxine Hydrochloride Extended-Release Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Venlafaxine Hydrochloride Extended-Release Capsules Production Mode & Process
  6. 9.2 Venlafaxine Hydrochloride Extended-Release Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Venlafaxine Hydrochloride Extended-Release Capsules Distributors
  9. 9.2.3 Venlafaxine Hydrochloride Extended-Release Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst